Avaliação da qualidade de vida dos pacientes tratados de câncer de boca, orofaringe e laringe no Centro de Oncologia Bucal

• Autor(a) principal: Cortiglio, Salmo [UNESP]
• Data de Publicação: 2014
• Tipo de documento: Trabalho de conclusão de curso
• Idioma: por
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://hdl.handle.net/11449/149588; http://www.athena.biblioteca.unesp.br/exlibris/bd/capelo/2017-01-27/000867197.pdf
• topic: Qualidade de vida; Neoplasias de cabeça e pescoço; Carcinoma de células escamosas; Neoplasias bucais; Neoplasias orofaríngeas; Neoplasias laríngeas; Quality of life

Analysis of Quality of Life (QOL) in patients affected by head and neck cancer is important, since the treatment of this disease brings, often with aesthetic, functional and psychosocial sequelae, which are not possible to be measured in objective analysis, requiring the patient expresses your emotional state on the stage that is experiencing. Thus, this study aims to examine the QOL of patients treated for mouth cancer, oropharynx and larynx at the Center of Oral Oncology. This study analyzed 53 patients who completed the treatment and were followed at the Center of Oral Oncology (COB). Patients were grouped according to duration of post-treatment in both groups. Group I treated for less than a year and the group II one year or more .Were also divided into subgroups according to age, clinical staging, treatment modality and gender. Through interviews, the questionnaire was applied at the University of Washington-UW-QOL, (4th version); data were edited and tabulated in Excel 2007 program As for the old domain was looking more towards the younger patients; patients in advanced stage showed lower mean scores of the domains relative to that were staged in the initial phase; only to surgery showed better scores when compared with combined treatment modalities; saliva was the area that most negatively influenced the QOL of patients during the last week prior to the application of the UW-QOL. The higher QOL scores were obtained for patients treated for a year or more with the exception of patients with less than 60 years and female patients there